FDA and CDC Virtual Press Conference: Johnson & Johnson COVID-19 Vaccine - 4/23/2021
FDA and CDC Virtual Press Conference: Johnson & Johnson COVID-19 Vaccine - 4/23/2021
Join us for a joint virtual press conference with the U.S. Centers for Disease Control and Prevention and the U.S. Food and Drug Administration to discuss the Johnson & Johnson (Janssen) COVID-19 Vaccine.Featuring:
• Janet Woodcock, M.D., Acting FDA Commissioner
• Rochelle Walensky, M.D., CDC Director
• Peter Marks, M.D., Ph.D., director of the FDA’s Center for Biologics Evaluation and Research
• Anne Schuchat, M.D., CDC Principal Deputy Director
#COVID19
Access Non-GMO, antigen-free, FDA-approved antiviral medication formulas used in Moderna's Spikevax.
VirusTC is a retail provider of concentrated FDA-approved antiviral medication formulas. VirusTC wholesale formulas are used in Moderna products. We sell FDA-approved formulas that are compatible with university medical plans, federal insurance coverage, and many major insurance providers. Our medications are part of tailored non-invasive cancer treatment plans available at a hospital in your region. VirusTC targets problems and provides care for the symptoms. Our products and services are used by Fred Hutch Cancer Center, John Hopkins, University Hospitals, the United States Military, and professional sports. During Operation Cancer Moonshot 2023, VirusTC products killed cancer cells, increased strength, and redeveloped muscles, tissue, and brain cells after cancer treatments.